<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    Tiziana Life Sciences plc

    verified_userVerify Profile
    Companies » Health Care » Pharmaceuticals & Biotechnology » Pharmaceuticals

    About Tiziana Life Sciences plc

    Tiziana Life Sciences is a dual-listed (NASDAQ:TLSA, AIM:TILS) clinical stage biotechnology company that specializes in the developing transformative therapies for inflammatory diseases and cancer related to the liver. Our clinical pipeline includes drug assets for NASH, Crohn's, and hepatocellular carcinoma. Tiziana is led by a team of highly qualified executives with extensive drug development and commercialization experience. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      2834
    • NIN CODE
      ####
    • LEADERSHIP
      Kunwar Shailubhai PhD
    • FOUNDED
      2013
    • EMPLOYEES
      0-10
    • SECTOR
      Pharmaceuticals & Biotechnology
    • SUBSECTOR
      Pharmaceuticals

    Company Tags

    No articles found.

    NantHealth, Inc.

    NantHealth, Inc.

    NantHealth is a next-generation, evidence-based, personalized healthcare company e...

    NantHealth is a next-generation, evidence-based...

    Filing Type:    PU
    Athenex, Inc.

    Athenex, Inc.

    Athenex is a global oncology focused biopharmaceutical company dedicated to the di...

    Athenex is a global oncology focused biopharmac...

    Filing Type:    PU
    World Health Organization

    World Health Organization

    The World Health Organization is an international organization that directs and co...

    The World Health Organization is an internation...

    Filing Type:    PR
    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc.

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a responsibly-driven company focused o...

    Seelos Therapeutics, Inc. (Nasdaq: SEEL) is a r...

    Filing Type:    PU
    Homology Medicines, Inc.

    Homology Medicines, Inc.

    Homology Medicines, Inc. is a genetic medicines company dedicated to transforming ...

    Homology Medicines, Inc. is a genetic medicines...

    Filing Type:    PU
    Trevi Therapeutics, Inc.

    Trevi Therapeutics, Inc.

    We are developing nalbuphine ER to treat serious neurologically mediated condition...

    We are developing nalbuphine ER to treat seriou...

    Filing Type:    PU
    Galmed Pharmaceuticals Ltd.

    Galmed Pharmaceuticals Ltd.

    Galmed is a clinical-stage biopharmaceutical company focused on the development of...

    Galmed is a clinical-stage biopharmaceutical co...

    Filing Type:    PU
    Dicerna Pharmaceuticals, Inc.

    Dicerna Pharmaceuticals, Inc.

    Dicerna is a biopharmaceutical company focused on the discovery and development of...

    Dicerna is a biopharmaceutical company focused ...

    Filing Type:    PU
    Albireo Pharma, Inc.

    Albireo Pharma, Inc.

    Albireo is a clinical-stage biopharmaceutical company focused on the development a...

    Albireo is a clinical-stage biopharmaceutical c...

    Filing Type:    PU
    ©2025 National Investor Network. All Rights Reserved.